Mutual funds holding both Embassy Developments and Strides Pharma Science

Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 4 mutual funds hold active equity positions in both Embassy Developments and Strides Pharma Science. The scheme with the highest combined exposure is quant Multi Cap Fund (Quant MF), which holds a 1.84% stake in Embassy Developments and a 1.89% stake in Strides Pharma Science, amounting to a combined conviction weight of 3.72%.

When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.